HES
49
2
TROW
37
8
AES
47
4
CVX
25
14
ZION
49
9
CF
47
5
TMO
52
8
DRI
74
5
GIS
47
13
PSX
24
2
SYF
78
7
NWSA
69
4
MHK
25
5
DUK
49
4
CNX
67
4
ITW
45
2
DOW
47
4
DIS
70
2
SHW
42
5
FCX
44
4
HES
49
2
TROW
37
8
AES
47
4
CVX
25
14
ZION
49
9
CF
47
5
TMO
52
8
DRI
74
5
GIS
47
13
PSX
24
2
SYF
78
7
NWSA
69
4
MHK
25
5
DUK
49
4
CNX
67
4
ITW
45
2
DOW
47
4
DIS
70
2
SHW
42
5
FCX
44
4
Financhill
Back

Precision BioSciences Vs. Protagonist Therapeutics Industry Stock Comparison

Sell
17

DTIL
Precision BioSciences

Last Price:
$4.73
Seasonality Move:
-21.67%
Sell
48

PTGX
Protagonist Therapeutics

Last Price:
$41.51
Seasonality Move:
28.98%
Sell
17
Precision BioSciences (DTIL) is a Sell

Is Precision BioSciences a Buy, Sell or Hold?

  • The current Precision BioSciences [DTIL] share price is $4.79. The Score for DTIL is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • DTIL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $41.49. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DTIL Stock Price Chart

What is Precision BioSciences's stock price today?

  • The Precision BioSciences share price today is $4.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DTIL is experiencing slight buying pressure.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $41.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

DTIL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 33.48 Sell
Chaikin Money Flow: 6019 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.17 - 7.17) Sell
Bollinger Bands (100): (6.9 - 9.92) Sell

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.97 Sell
Relative Strength Index (14 RSI): 48.12 Sell
Chaikin Money Flow: 2020409 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.8 - 43.7) Sell
Bollinger Bands (100): (40.18 - 46.28) Sell

DTIL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5 Sell
20-day SMA: 5.93 Sell
50-day SMA: 7.35 Sell
200-day SMA: 9.9 Sell
8-day EMA: 4.97 Sell
20-day EMA: 5.77 Sell
50-day EMA: 7 Sell
200-day EMA: 9.98 Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.59 Buy
20-day SMA: 42.06 Sell
50-day SMA: 43.96 Sell
200-day SMA: 37.02 Buy
8-day EMA: 40.69 Buy
20-day EMA: 41.55 Sell
50-day EMA: 42.69 Sell
200-day EMA: 37.72 Buy

Precision BioSciences Earnings Growth & DTIL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.23 per share, and a decrease next year of $9.65 per share.

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.57 per share, and a decrease next year of $3.76 per share.

Precision BioSciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):